Browse Category

NYSE:TOST News 19 December 2025

Toast (TOST) Stock News on Dec. 19, 2025: Analyst Targets Reset, 2026 Outlook Signals, and What Investors Are Watching

Toast (TOST) Stock News on Dec. 19, 2025: Analyst Targets Reset, 2026 Outlook Signals, and What Investors Are Watching

Toast, Inc. (NYSE: TOST) stock is ending 2025 with the kind of “quietly dramatic” setup markets love: a fast-growing restaurant-tech platform, improving profitability, and a fresh wave of analyst notes that trim price targets while keeping bullish ratings intact. In the latest available quote, Toast shares were around $36.62, up about 3% from the prior close. Investing.com So what’s driving the conversation around Toast stock on 19.12.2025? Three threads stand out: Toast stock price action: where TOST stands heading into the Dec. 19 news cycle On the most recent completed session shown in Investing.com’s daily history, Toast closed Dec. 18,

Stock Market Today

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026
New York, February 7, 2026, 05:48 EST — Market closed Pfizer Inc (PFE) shares ended Friday up 2.8% at $27.22, after trading between $26.52 and $27.37. About 50.7 million shares changed hands. (Yahoo Finance) The stock’s late-week lift comes with a key regulatory clock running: the FDA granted priority review for Pfizer’s supplemental filing to broaden use of its hemophilia drug Hympavzi, with a target decision deadline in the second quarter. Priority review shortens the agency’s standard review timeline by four months. “There is a significant medical need for younger patients with hemophilia and for those who have developed inhibitors,”
Go toTop